The Board has determined that the veteran's thrombocytosis, currently diagnosed as leukemia, was not incurred in or aggravated by active service and denied her claim for service connection.
The deciding factor: The VA examiner found no direct evidence of exposure to hazardous materials during service and concluded that there is no link between the veteran's current condition and her military service.
- Claimed conditions
- thrombocytosis, leukemia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- March 8, 2006
- Citation
- 0606670
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board denied service connection for a blood disorder of acquired autoimmune hemolytic anemia (AIHA) and remanded the issue of entitlement to service connection for a blood disorder of myelodysplastic/myeloproliferative neoplasms (MDN/MPN) with neutrophilia/atypical chronic myeloid leukemia (CML).
- Partly granted
The Board granted service connection for bilateral tinnitus with an effective date of January 4, 2022, but no earlier. Service connection was also granted for an acquired psychiatric disorder to include depression and posttraumatic stress disorder (PTSD).
- Remanded (sent back)
The Board remands the claim for service connection for leukemia to ensure the Veteran is afforded a VA examination and an opinion on the etiology of his condition, as well as to determine if he participated in any toxic exposure risk activities during service.
- Dismissed
The Board dismissed the claims for service connection for gout, migraine headaches, and a back condition as untimely. The claim for a compensable evaluation of thrombocytosis was denied due to lack of evidence supporting continuous or intermittent myelosuppressive therapy, chemotherapy, or interferon treatment. The issues regarding sleep apnea and myelofibrosis with abnormal weight loss were remanded for further examination.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.